Skip to Content

Tag: CPAP


Also Noted

NY Medicaid unbundles CPAP benefit 

May 17, 2022HME News Staff

ALBANY, N.Y. – New York State Medicaid will unbundle all CPAP and BiPAP supplies from new set ups effective June 1, AAHomecare reports. The program has also unbundled heated humidifiers and cool humidifiers, according to a 202-page DME Manual Update. Additionally, the program has made it an option to purchase PAP devices or rent them as a 10-month capped rental. NEMEP’s Payer Relations Committee, chaired by David Chandler of AAHomecare, and NEMEP President John Quinlan worked with Medicaid...

aahomecare, CPAP, New York State Medicaid


Read Full Articlered right arrow icon

Steve Griggs

Providers

AdaptHealth takes long view of CPAP market

May 13, 2022Theresa Flaherty, Managing Editor

PLYMOUTH MEETING, Pa. – Acquisitions will continue to be a big part of AdaptHealth’s strategy, but how much will depend on how the market for CPAP devices unfolds throughout 2022, company execs said on a recent earnings call.  “Depending on supply and the availability of product in the back half of the year, we could dial up or dial down our ability to do integrations and acquisitions,” said Josh Parnes, president.   In 2021, AdaptHealth closed on 23 acquisitions,...

AdaptHealth, CPAP, Steve Griggs


Read Full Articlered right arrow icon

Also Noted

RemSleep applications advances

May 10, 2022HME News Staff

TAMPA, Fla. – RemSleep Holdings says it has responded to the Additional Information request related to its 510(k) application to the U.S. Food and Drug Administration for its patented DeltaWave nasal mask CPAP interface. “This submission is expected to be the final step and pivotal moment for our company,” said CEO Tom Wood. “It will dramatically strengthen the commercialization of our brand and make the DeltaWave a premier product that reinforces our commitment to providing...

CPAP, DeltaWave, RemSleep


Read Full Articlered right arrow icon

Vendors

Philips recall: FDA proposes new order

May 4, 2022HME News Staff

WASHINGTON – The Food and Drug Administration’s Center for Devices and Radiologic Health has proposed that an order should be issued to require Philips to submit a plan to repair, replace or refund the purchase price of recalled devices manufactured after November 2015.  The FDA says Philips has the right to an informal hearing prior to the agency’s decision on whether to issue the order.  The CDRH’s proposal is in addition to the FDA’s previous...

CPAP, Home Respiratory Equipment, Philips Recall


Read Full Articlered right arrow icon

Frans van houten

Vendors

Philips on recall: ‘We are progressing very well’

April 29, 2022Liz Beaulieu, Editor

AMSTERDAM, the Netherlands – Philips’ plan to remediate an additional 300,000 devices will push the completion date of its recall into 2023, but the company recorded additional provisions in the first quarter to speed up the process as much as it can.  Philips now expects to complete more than 90% of production and shipments to customers by the end of 2022, said Frans van Houten, CEO, during an April 25 conference call to discuss the company’s financial results for...

CPAP, Philips Respironics, Recall


Read Full Articlered right arrow icon

News

In brief: Quipt acquires, Humana divests, F&P debuts

April 22, 2022HME News Staff

CINCINNATI – Quipt Home Medical has acquired Good Night Medical, a business with operations across seven states, for about $7 million in cash.  The acquisition provides Quipt Home Medical with expansion opportunities into Massachusetts, North Carolina and Texas, where it doesn’t have a presence.  “Good Night Medical strengthens our healthcare network across multiple states, enhancing our national coverage sphere over an area that includes about 5 million COPD sufferers...

ACHC, CPAP, Fisher & Paykel, Good Night Medical, Harmar, Humana, Orthotics, Quipt Home Medical


Read Full Articlered right arrow icon

newspoll logo

News

CPAP therapy: Advanced capabilities complicate challenges

March 25, 2022Liz Beaulieu, Editor

YARMOUTH, Maine – A majority of sleep physicians and patients have been reluctant to prescribe and use different brands of CPAP devices, despite a recall and supply chain challenges that are limiting access to products, according to a recent HME Newspoll.  A big reason for that, respondents say: Philips and ResMed, which are the most widely prescribed and used, have the most sophisticated compliance tracking and reporting capabilities.  “Although many are upset with Philips,...

CPAP, Philips Recall


Read Full Articlered right arrow icon

News

DME provider files lawsuit against Philips

March 16, 2022HME News Staff

PHILADELPHIA – Baird Respiratory Therapy has filed a lawsuit against Philips, claiming it and other DME suppliers are owed refunds for recalled respiratory devices containing PE-PUR sound abatement foam, according to Law360.   The complaint, filed March 9 in the U.S. District Court for the Eastern District of Pennsylvania, seeks class action status on behalf of all similarly affected suppliers, arguing that Philips breached its warranty and misrepresented the risk...

Baird Respiratory, CPAP, Philips Recall


Read Full Articlered right arrow icon

Steve Griggs

Providers

AdaptHealth adjusts expectations for 2022

February 25, 2022Theresa Flaherty, Managing Editor

PLYMOUTH MEETING, Pa. – A larger than expected hit from the Philips CPAP recall in the fourth quarter of 2021 is creating an overhang on 2022, but AdaptHealth says it expects to take a significant share of the patient backlog when the situation improves.  The company had previously estimated the recall’s financial impact in 2022 to be in the neighborhood of $20 million, but said during an earnings call last week that number is closer to $65 million.  “It was...

AdaptHealth, CPAP, Home Medical Equipment, Philips Recall


Read Full Articlered right arrow icon

Steve Griggs

Providers

AdaptHealth booming, despite CPAP shortage, pandemic

February 24, 2022HME News Staff

PLYMOUTH MEETING, Mass. – AdaptHealth more than doubled its revenue in 2021, with reporting $2.45 billion, up from $1.06 billion in 2020.  “2021 was a remarkable year for AdaptHealth,” said Steve Griggs, CEO. “Despite the worldwide pandemic, the shortage of CPAP equipment, and higher costs from supply chain challenges, AdaptHealth has continued to grow and prosper. Although adjusted EBITDA fell short of our full-year guidance due to product mix shift from rental to...

AdaptHealth, CPAP, Home Medical Equipment, Philips Recall


Read Full Articlered right arrow icon